PA
ROIV icon

Perceptive Advisors’s Roivant Sciences ROIV Stock Holding History

Perceptive Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286M Sell
8,085,461
-200,000
-2% -$5.91M 4.3% 6
2026
Q1 		$230M Buy
8,285,461
+300,000
+4% +$7.71M 4.48% 4
2025
Q4 		$173M Buy
7,985,461
+617,000
+8% +$12.2M 3.09% 6
2025
Q3 		$111M Buy
7,368,461
+4,036,996
+121% +$50M 3.22% 8
2025
Q2 		$37.5M Buy
+3,331,465
New +$36.1M 1.39% 18
2024
Q4 		– Sell
-847,745
Closed -$9.78M – 115
2024
Q3 		$9.78M Buy
+847,745
New +$9.65M 0.21% 71
2023
Q4 		– Sell
-3,819,456
Closed -$44.6M – 113
2023
Q3 		$44.6M Buy
3,819,456
+687,720
+22% +$7.77M 1.49% 21
2023
Q2 		$31.6M Buy
3,131,736
+439,600
+16% +$3.93M 0.91% 34
2023
Q1 		$19.9M Buy
2,692,136
+710,566
+36% +$5.85M 0.59% 46
2022
Q4 		$15.8M Buy
+1,981,570
New +$11M 0.44% 48

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Perceptive Advisors's ROIV Position: Q2 2026 in Review

Perceptive Advisors reduced its Roivant Sciences (ROIV) stake by 2.4% in Q2 2026, selling an estimated $5.91M and leaving 8,085,461 shares worth $286M. The position accounts for 4.3% of the portfolio, ranked #6.

Perceptive Advisors first reported a position in ROIV in Q4 2022 and has held it in 10 quarters since. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Perceptive Advisors held 8,085,461 shares of Roivant Sciences worth $286M as of Q2 2026.
  • Perceptive Advisors sold 200,000 Roivant Sciences shares in Q2 2026, an estimated $5.91M.
  • Roivant Sciences made up 4.3% of Perceptive Advisors's portfolio in Q2 2026, its #6 holding.
  • Perceptive Advisors first reported a position in Roivant Sciences in Q4 2022 and has held it in 10 quarters since.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.